Pharmacogenetic considerations for acute lymphoblastic leukemia therapies

Author: Dulucq Stéphanie   Laverdière Caroline   Sinnett Daniel   Krajinovic Maja  

Publisher: Informa Healthcare

ISSN: 1742-5255

Source: Expert Opinion on Drug Metabolism and Toxicology, Vol.10, Iss.5, 2014-05, pp. : 699-719

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next